For example, Vilar et al. demonstrated that human CRC cell lines that were MSI-H due to hMLH1 inactivation were four to nine times more sensitive to topoisomerase I inhibition compared to MSS cell lines [87]. The gene discussed is MLH1; the disease is colorectal carcinoma.